Current File : /var/www/html/geotechnics/api/public/pvwqg__5b501ce/cache/bd38a796e826e6cff64b20aa6f0922b7
a:5:{s:8:"template";s:3196:"<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html lang="en">
<head profile="http://gmpg.org/xfn/11">
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<title>{{ keyword }}</title>
<style rel="stylesheet" type="text/css">@font-face{font-family:Roboto;font-style:normal;font-weight:400;src:local('Roboto'),local('Roboto-Regular'),url(https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxP.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfBBc9.ttf) format('truetype')} html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}a{background-color:transparent}a:active,a:hover{outline:0}h1{margin:.67em 0;font-size:2em}/*! Source: https://github.com/h5bp/html5-boilerplate/blob/master/src/css/main.css */@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}p{orphans:3;widows:3}} *{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}h1{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}h1{margin-top:20px;margin-bottom:10px}h1{font-size:36px}p{margin:0 0 10px}@-ms-viewport{width:device-width}html{height:100%;padding:0;margin:0}body{font-weight:400;font-size:14px;line-height:120%;color:#222;background:#d2d3d5;background:-moz-linear-gradient(-45deg,#d2d3d5 0,#e4e5e7 44%,#fafafa 80%);background:-webkit-linear-gradient(-45deg,#d2d3d5 0,#e4e5e7 44%,#fafafa 80%);background:linear-gradient(135deg,#d2d3d5 0,#e4e5e7 44%,#fafafa 80%);padding:0;margin:0;background-repeat:no-repeat;background-attachment:fixed}h1{font-size:34px;color:#222;font-family:Roboto,sans-serif;font-weight:900;margin:20px 0 30px 0;text-align:center}.content{text-align:center;font-family:Helvetica,Arial,sans-serif}@media(max-width:767px){h1{font-size:30px;margin:10px 0 30px 0}} </style>
<body>
</head>
<div class="wrapper">
<div class="inner">
<div class="header">
<h1><a href="#" title="{{ keyword }}">{{ keyword }}</a></h1>
<div class="menu">
<ul>
<li><a href="#">main page</a></li>
<li><a href="#">about us</a></li>
<li><a class="anchorclass" href="#" rel="submenu_services">services</a></li>
<li><a href="#">contact us</a></li>
</ul>
</div>
</div>
<div class="content">
{{ text }}
<br>
{{ links }}
</div>
<div class="push"></div>
</div>
</div>
<div class="footer">
<div class="footer_inner">
<p>{{ keyword }} 2021</p>
</div>
</div>
</body>
</html>";s:4:"text";s:7595:"Item 2.02. Senseonics Holdings, Inc. (NYSE:SENS) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants. Investor News. Contacts Senseonics Investor Contact Lynn Lewis or Philip Taylor Investor Relations 415-937-5406 investors@senseonics.com Senseonics Media Contact: Mirasol Panlilio 301-556-1631 Mirasol.panlilio@senseonics⦠Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a virtual analyst and investor event on Tuesday, September 15, 2020 at 4:30pm ET. Contacts. Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended June 30, 2020. About Senseonics. About Senseonics. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 ⦠Yahoo News Special Report. Philip Taylor - Investor Relations. Shweta's Secrets, Nudity and Kisses Caught on Cam: Bizarre Zoom Fails ⦠Schedules First Quarter 2021 Earnings Release and Conference Call for May 13, 2021 at 4:30 p.m. Eastern Time.. Get the hottest stocks to trade every day before the market ⦠The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to âInvestor Relations,â and ⦠Senseonics Holdings, Inc. (NYSE:SENS) Q4 2019 Earnings Conference Call March 12, 2020 4:30 PM ET Company Participants. Webcasts and presentations that have been archived are available by viewing historical event ⦠Philip Taylor-- Investor Relations Thank you very much, and welcome to the Senseonics first quarter 2019 earnings call. 1. December 23, 2020 - 1:49 PM PST. Senseonics Media Contact: Mirasol Panlilio 301-556-1631 Mirasol.panlilio@senseonics.com. GERMANTOWN, Md.--(BUSINESS WIRE)--Mar. Recent Posts. West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. Hereâs a few reasons why I think SENS stock surged today. Senseonics Submits PMA Application for 180-Day Eversense System to the FDA 10/05/2020 Senseonics Announces Analyst and Investor Event on September 15, 2020 09/08/2020 GERMANTOWN, MD, October 31, 2017 âSenseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, ⦠Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for March 4, 2021 at 4:30 p.m. Eastern Time.. Get the hottest stocks to trade every day before the market opens 100% free. Investor Relations 415-937-5406 Investors@senseonics.com Senseonics Media Contact: Mirasol Panlilio 301-556-1631. TRENDING. 2. 2. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. Senseonics Holdings Inc. [AMEX: SENS] traded at a low on 05/10/21, posting a -4.76 loss after which it closed the dayâ session at $1.80. E-mail Address. 1. 4, 2021-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported ⦠TRENDING. Interested parties may access a recorded webcast of the presentation on the "Investor Relations" section of the companyâs website at www.senseonics.com. Ketamine (CAS 6740-88-1) Global Market Research Report 2021 - ⦠Total suspends gas-linked cash payments to Myanmar army. Senseonics Holdings Inc. [AMEX: SENS] price plunged by -11.66 percent to reach at -$0.54. Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA. Download Presentation. Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring ⦠On May 13, 2021, Senseonics Holdings, Inc. (the âCompanyâ) issued a press release announcing its financial results for the quarter ended March 31, 2021, as well as information regarding a conference call to discuss these financial results and the Companyâs recent corporate highlights and outlook. Senseonics Investor Contact Lynn Lewis or Philip Taylor Investor Relations 415-937-5406 investors@senseonics.com . Senseonics Investor Relations Contact: Lynn Lewis or Philip Taylor Investor Relations 415-937-5406 Investors@senseonics.com. Investor Relations 415-937-5406 Investors@senseonics.com Senseonics Media Contact: Mirasol Panlilio 301-556-1631. Senseonics Announces Analyst and Investor Event on September 15, 2020. A replay of the call can be accessed on Senseonicsâ website https://www.senseonics.com under âInvestor Relations.â. Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, May 13, 2021. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER. Senseonics Investor Contact Lynn Lewis or Philip Taylor Investor Relations 415-937-5406 investors@senseonics.com. 2. TRENDING. Product Alerts Leadership Executive Team Board Of Directors Investor Relations Stock Information Events & Publications SEC Filings News Releases Corporate Governance Email Alerts Accessibility Careers Benefits Core Values Our People Vacancies Accessibility Products Products Product Alerts Leadership Executive Team Board Of Directors Senseonics Media Contact: Mirasol Panlilio 301-556-1631. Read More. Investor Relations 415-937-5406 Investors@senseonics.com. Browse the calendar to view Investor related events and announcements. All users should speak with their financial advisor before buying or selling any securities. About Senseonics and the Eversense Continuous Glucose Monitoring System Senseonics Holdings, Inc. (NYSE American: SENS) is a medical technology company focused on the design, development and commercialization of transformative glucose monitoring products designed to help people with diabetes ⦠Mr. Roeder serves as a director of Senseonics Holdings, Inc. (NYSE-MKT: SENS), a continuous glucose monitoring company, and several privately held companies. Our company was founded on May 5, 1999 with the goal of developing new ⦠Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio of ⦠GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2021.Recent Highlights & Accomplishments: ";s:7:"keyword";s:29:"senseonics investor relations";s:5:"links";s:698:"<a href="https://api.geotechnics.coding.al/pvwqg/dark-whisky-marmalade-recipe">Dark Whisky Marmalade Recipe</a>,
<a href="https://api.geotechnics.coding.al/pvwqg/signs-of-a-protective-boyfriend">Signs Of A Protective Boyfriend</a>,
<a href="https://api.geotechnics.coding.al/pvwqg/opposite-of-easy-in-spanish">Opposite Of Easy In Spanish</a>,
<a href="https://api.geotechnics.coding.al/pvwqg/andre-strawberry-champagne-calories">Andre Strawberry Champagne Calories</a>,
<a href="https://api.geotechnics.coding.al/pvwqg/golden-crust-pizza-red-lion-menu">Golden Crust Pizza Red Lion Menu</a>,
<a href="https://api.geotechnics.coding.al/pvwqg/saddle-row-rowing-machine">Saddle Row Rowing Machine</a>,
";s:7:"expired";i:-1;}
Mini Shell